AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $729,308 | -75.5% | 59,976 | -77.6% | 0.02% | -78.0% |
| Q1 2023 | $2,971,355 | +75.7% | 267,931 | +93.5% | 0.08% | +70.8% |
| Q4 2022 | $1,690,890 | +481.1% | 138,484 | +411.4% | 0.05% | +269.2% |
| Q2 2022 | $291,000 | +157.5% | 27,077 | +129.8% | 0.01% | +44.4% |
| Q3 2021 | $113,000 | -61.4% | 11,782 | -61.3% | 0.01% | -64.0% |
| Q2 2021 | $293,000 | -62.8% | 30,425 | -61.9% | 0.02% | -65.3% |
| Q1 2021 | $788,000 | -37.5% | 79,793 | +46.2% | 0.07% | -46.3% |
| Q4 2020 | $1,261,000 | +333.3% | 54,592 | +165.2% | 0.13% | +605.3% |
| Q3 2020 | $291,000 | -10.5% | 20,584 | -41.4% | 0.02% | -20.8% |
| Q1 2020 | $325,000 | +3.2% | 35,155 | -10.5% | 0.02% | -11.1% |
| Q3 2019 | $315,000 | -63.7% | 39,260 | -43.5% | 0.03% | -65.4% |
| Q2 2019 | $867,000 | +155.8% | 69,475 | +207.8% | 0.08% | +225.0% |
| Q1 2018 | $339,000 | -6.9% | 22,571 | -10.6% | 0.02% | -40.0% |
| Q4 2017 | $364,000 | +19.7% | 25,261 | +25.3% | 0.04% | -48.1% |
| Q3 2017 | $304,000 | -28.8% | 20,160 | -52.5% | 0.08% | -34.2% |
| Q2 2017 | $427,000 | -13.9% | 42,400 | -39.0% | 0.12% | +82.8% |
| Q1 2017 | $496,000 | +126.5% | 69,564 | +134.5% | 0.06% | +30.6% |
| Q3 2016 | $219,000 | -54.7% | 29,662 | -66.5% | 0.05% | -22.2% |
| Q2 2016 | $483,000 | +151.6% | 88,486 | +288.7% | 0.06% | +186.4% |
| Q1 2016 | $192,000 | -88.2% | 22,766 | -80.2% | 0.02% | -88.0% |
| Q2 2015 | $1,628,000 | +130.3% | 115,100 | +77.1% | 0.18% | +154.2% |
| Q1 2015 | $707,000 | +18.6% | 65,000 | -9.3% | 0.07% | -31.4% |
| Q4 2014 | $596,000 | – | 71,700 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |